Psoriasis in children

Roxanne Pinson,1 Bahman Sotoodian,2 Loretta Fiorillo2,3 1School of Medicine, 2Division of Dermatology and Cutaneous Sciences, Department of Medicine, 3Division of Pediatric Dermatology, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada Abstract: The clinical presentation, disease...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pinson R, Sotoodian B, Fiorillo L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/620b04783c3a41a5a4a2f0e4bc21c91f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:620b04783c3a41a5a4a2f0e4bc21c91f
record_format dspace
spelling oai:doaj.org-article:620b04783c3a41a5a4a2f0e4bc21c91f2021-12-02T01:12:44ZPsoriasis in children2230-326Xhttps://doaj.org/article/620b04783c3a41a5a4a2f0e4bc21c91f2016-10-01T00:00:00Zhttps://www.dovepress.com/psoriasis-in-children-peer-reviewed-article-PTThttps://doaj.org/toc/2230-326XRoxanne Pinson,1 Bahman Sotoodian,2 Loretta Fiorillo2,3 1School of Medicine, 2Division of Dermatology and Cutaneous Sciences, Department of Medicine, 3Division of Pediatric Dermatology, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada Abstract: The clinical presentation, disease associations, and diverse treatment modalities in overcoming the challenges of managing pediatric psoriasis have been extensively summarized in this article. An extensive literature review revealed the differences in presentation of psoriasis during infancy, childhood, and adolescence. We also summarized the latest topical, systemic, and biological modalities in treating recalcitrant psoriasis. The association of psoriasis with juvenile arthritis and obesity and the significant influence of the disease on the children's quality of life were explored. The clinical presentation of psoriasis can evolve during the child's lifespan. While many treatment modalities already exist for treating pediatric psoriasis, some of the new biologics that are approved for adult patients have not been investigated in the pediatric population and no algorithm exists for their use in this population. Large clinical studies in the future will enhance our understanding with regards to their safety and potential implications in pediatric populations. Keywords: pediatric, epidemiology, juvenile arthritis, topical treatment, systemic treatment, phototherapy, biologicsPinson RSotoodian BFiorillo LDove Medical PressarticlePsoriasisPediatricEpidemiologyJuvenile arthritisTopical treatmentSystemic treatmentPhototherapyBiologicsDermatologyRL1-803ENPsoriasis: Targets and Therapy, Vol Volume 6, Pp 121-129 (2016)
institution DOAJ
collection DOAJ
language EN
topic Psoriasis
Pediatric
Epidemiology
Juvenile arthritis
Topical treatment
Systemic treatment
Phototherapy
Biologics
Dermatology
RL1-803
spellingShingle Psoriasis
Pediatric
Epidemiology
Juvenile arthritis
Topical treatment
Systemic treatment
Phototherapy
Biologics
Dermatology
RL1-803
Pinson R
Sotoodian B
Fiorillo L
Psoriasis in children
description Roxanne Pinson,1 Bahman Sotoodian,2 Loretta Fiorillo2,3 1School of Medicine, 2Division of Dermatology and Cutaneous Sciences, Department of Medicine, 3Division of Pediatric Dermatology, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada Abstract: The clinical presentation, disease associations, and diverse treatment modalities in overcoming the challenges of managing pediatric psoriasis have been extensively summarized in this article. An extensive literature review revealed the differences in presentation of psoriasis during infancy, childhood, and adolescence. We also summarized the latest topical, systemic, and biological modalities in treating recalcitrant psoriasis. The association of psoriasis with juvenile arthritis and obesity and the significant influence of the disease on the children's quality of life were explored. The clinical presentation of psoriasis can evolve during the child's lifespan. While many treatment modalities already exist for treating pediatric psoriasis, some of the new biologics that are approved for adult patients have not been investigated in the pediatric population and no algorithm exists for their use in this population. Large clinical studies in the future will enhance our understanding with regards to their safety and potential implications in pediatric populations. Keywords: pediatric, epidemiology, juvenile arthritis, topical treatment, systemic treatment, phototherapy, biologics
format article
author Pinson R
Sotoodian B
Fiorillo L
author_facet Pinson R
Sotoodian B
Fiorillo L
author_sort Pinson R
title Psoriasis in children
title_short Psoriasis in children
title_full Psoriasis in children
title_fullStr Psoriasis in children
title_full_unstemmed Psoriasis in children
title_sort psoriasis in children
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/620b04783c3a41a5a4a2f0e4bc21c91f
work_keys_str_mv AT pinsonr psoriasisinchildren
AT sotoodianb psoriasisinchildren
AT fiorillol psoriasisinchildren
_version_ 1718403203065708544